Hemodilution Validation of INVSENSOR00026

Masimo

Status

Completed

Conditions

Healthy

Treatments

Device: INVSENSOR00026

Study type

Interventional

Funder types

Industry

Identifiers

NCT03677375

TP-19466

Details and patient eligibility

About

In this study, the concentration of hemoglobin within the subject's blood will be reduced in a controlled manner by administering fluids intravenously. The accuracy of a noninvasive hemoglobin sensor will be assessed by comparison to hemoglobin measurements from a laboratory analyzer.

Enrollment

173 patients

Sex

All

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Subject weighs a minimum of 110 lbs and no more than 250 lbs unless subject is over 6 feet tall.
Hemoglobin value is greater than or equal to 11 g/dL at time of screening
Baseline heart rate ≥ 45 bpm and ≤ 85 bpm.
CO value ≤ 2.0% FCOHb
Subject has a physical status of ASA I or II (American Society of Anesthesiology Class I; Healthy subjects without any systemic disease at all. American Society of Anesthesiology Class II; subjects with mild systemic disease) as it applies to the systemic disease portion of the classification.
Systolic Blood Pressure ≤ 140 mmHg and Diastolic Blood Pressure ≤ 90 mmHg.
Subject is able to read and communicate in English and understands the study and risks involved.

Exclusion criteria

Subject is pregnant
Subject smokes (including e-cigarette use)
Subject has a BMI > 35 and has been classified as morbidly obese or at an increased risk for participation by a medical professional.
Subject has a history of fainting (vasovagal), blacking out or losing consciousness during or after a blood draw.
Subject has open wounds, inflamed tattoos or piercings, or any visible healing wounds.
Subject has known drug or alcohol abuse or uses recreational drugs.
Subject has experienced a head injury with loss of consciousness within the last year.
Subject has taken anticoagulant medication within the last 30 days.
Subject has any chronic bleeding disorders (i.e. hemophilia).
Subject has any history of a stroke, myocardial infarction, heart attack, or seizures.
Subject has any cancer or history of cancer (not including skin cancer).
Subject has a chronic neurological disease (i.e. multiple sclerosis, Huntington's disease).
Subject has any cardiac dysrhythmias (i.e. atrial fibrillation) and has not received clearance from their physician.
Subject has known neurological and/or psychiatric disorder (i.e. schizophrenia, bipolar disorder) that interferes with the subject's level of consciousness.
Subject has Wolff-Parkinson-White Syndrome or Stokes-Adams Syndrome
Subject has any medical condition which in the judgment of the investigator and/or medical staff, renders them ineligible for participation in this study (Discretion of investigator).
Subject has taken opioid pain medication within 24 hours of start of study.
Subject has any type of infectious disease (i.e. Hepatitis, HIV, Tuberculosis, Flu, Malaria, Measles, etc.).
Subject is taking medications known to treat any type of infectious disease.
Subject has either signs or history of peripheral ischemia or carpal tunnel.
Subject has had invasive surgery within the past year- including but not limited to major dental surgery, gallbladder, heart, appendix, major fracture repairs (involving plates/ screws), jaw surgery, Urinary tract surgery, plastic surgery, major ENT surgery, joint replacement or gynecological surgeries, heart surgery or thoracic surgery.
Subject has symptoms of congestion, head colds, flu, or other illnesses
Subject has donated blood within the last 2 weeks.
Subject is claustrophobic or has generalized anxiety disorder.
Subject has been in severe car accident(s) or a similar type of accident(s) requiring hospitalization within the last 12 months.
Subject has had a concussion within the last 12 months.
Subject has chronic unresolved asthma, lung disease or respiratory disease.
Subject is allergic to lidocaine, latex, adhesives, or plastic.
Subject has heart conditions, insulin-dependent diabetes or uncontrolled hypertension.
Subject has delivered vaginally, has had a pregnancy terminated, a miscarriage with hospitalization, or had a C-section within the last 6 months.
Subject intends on participating in any heavy lifting, repetitive movement of their wrist (including riding a motorcycle) or exercise (working out, riding a bike, riding a skate board etc.), or any activity that will put additional stress on the wrist within 24 hours following a study that involves an arterial line.
Discretion of investigator/study staff